Rachel Presti

Medicine & Life Sciences

1. SARS Virus 100%
2. HIV 67%
3. Coronavirus 57%
4. Vaccination 49%
5. Vaccines 46%
6. HIV-1 36%
7. Messenger RNA 34%
8. Severe Acute Respiratory Syndrome 34%
9. Infections 25%
10. HIV Infections 25%
11. T-Lymphocytes 21%
12. Muromegalovirus 20%
13. Viruses 20%
14. Chronic Disease 19%
15. Microbiota 19%
16. B-Lymphocytes 18%
17. Antibodies 18%
18. Natural Killer Cell Receptors 16%
19. Germinal Center 16%
20. Primary Immunodeficiency Diseases 16%
21. Natural Killer Cells 16%
22. Tenofovir 16%
23. Antibody Formation 16%
24. Ritonavir 15%
25. Cytomegalovirus Infections 14%
26. Reverse Transcriptase Inhibitors 14%
27. Inflammasomes 14%
28. Human Influenza 14%
29. Interferons 13%
30. Atazanavir Sulfate 13%
31. Placebos 12%
32. Randomized Controlled Trials 12%
33. Antiviral Agents 11%
34. Quaranfil virus 11%
35. Immunologic Deficiency Syndromes 10%
36. Lung Diseases 10%
37. Virus Diseases 10%
38. HIV Integrase 10%
39. Serum 10%
40. CD4 Lymphocyte Count 10%
41. Human immunodeficiency virus 1 p16 protease 10%
42. Hepatitis Delta Virus 10%
43. Therapeutics 10%
44. Chad 9%
45. lamivudine drug combination abacavir 9%
46. dolutegravir 9%
47. Emtricitabine 9%
48. African Swine Fever Virus 9%
49. Acquired Immunodeficiency Syndrome 9%
50. Macrophages 9%